why choose us

First received: August 17, 2023

Clinical Trial: A Study of Avutometinib and Defactinib in People With Thyroid Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Thyroid Cancer

Study Type: INTERVENTIONAL


Official Title: Phase II of Avutometinib (VS-6766) and Defactinib In RAF Dimer-Driven RAI-Refractory Differentiated and Anaplastic Thyroid Cancer Patients

Brief Summary: The researchers are doing this study to find out if the combination of avutometinib and defactinib is an effective treatment for RAF dimer-driven radioiodine-refractory differentiated thyroid cancer or anaplastic thyroid cancer.The researchers will also test whether avutometinib and defactinib is a safe treatment that causes few or mild side effects.

Read more